vasogenic

vasogenic

/vaso·gen·ic/ (va″zo-jen´ik) originating in the blood vessels.

vasogenic

emanating from or pertaining to blood vessels.

vasogenic circulatory failure
see vasogenic shock.
References in periodicals archive ?
Within a few weeks of thiamine depletion, there is a reduction in the activity of the enzymes involved, the end-result being loss of the osmotic gradients in astrocytes and neuronal tissue, with vasogenic and cytotoxic oedema and subsequent cell necrosis.
The genesis of peritumoral vasogenic brain edema and tumor cysts: a hypothetical role for tumor-derived vascular permeability factor.
6 cm ring-enhancing lesion within the posterior aspect of the right frontal lobe that had mild surrounding vasogenic edema and local mass effect-findings that are typical for a pyogenic abscess (Figure 1a).
Simultaneously, AQP4 facilitated the clearance of vasogenic cerebral edema in pathologies where edema fluid accumulates in the extracellular space (Papadopoulos et al.
They tend to have no surrounding mass effect or vasogenic edema, unless complicated by superimposed hemorrhage.
The baby was diagnosed with life-threatening bacterial poisoning resulting from hypoxemia caused by vasogenic shock, poisoning, and low vascular perfusion that led to bluish limbs due to the lack of adequate oxygen.
However, the BBB becomes permeable to mannitol and it may worsen vasogenic oedema.
CT and MRI demonstrate surrounding vasogenic oedema, mass effect and ring enhancement of the abscess.
A follow-up computed tomography of the brain demonstrated the area of infarct with worsened surrounding vasogenic edema and midline shift of structures (see Figure 1).
In this condition, plasma and red blood cells are transferred into the extracellular space and vasogenic edema develops.
Vasospasm could occur as a result of exposure of spinal cord to red blood cells and inflammatory mediators and vasogenic edema could result from the breakdown of blood-spinal cord barrier.
The incidence of vasogenic edema (ARIA-E) was approximately 1 percent, occurring in 11 patients treated with solanezumab and 5 patients on placebo, which was not statistically significant.